| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20765400P | 2000-05-26 | 2000-05-26 | |
| US207654P | 2000-05-26 | ||
| PCT/US2001/016654WO2001091780A1 (en) | 2000-05-26 | 2001-05-23 | Neuroprotective peptides |
| Publication Number | Publication Date |
|---|---|
| EP1296702A1 EP1296702A1 (en) | 2003-04-02 |
| EP1296702A4true EP1296702A4 (en) | 2005-05-11 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP01941562AWithdrawnEP1296702A4 (en) | 2000-05-26 | 2001-05-23 | Neuroprotective peptides |
| Country | Link |
|---|---|
| EP (1) | EP1296702A4 (en) |
| JP (1) | JP2003534384A (en) |
| CN (1) | CN1318084C (en) |
| AU (2) | AU2001274904B2 (en) |
| BR (1) | BR0111182A (en) |
| CA (1) | CA2410453A1 (en) |
| IL (1) | IL153079A0 (en) |
| MX (1) | MXPA02011727A (en) |
| NZ (1) | NZ522924A (en) |
| WO (1) | WO2001091780A1 (en) |
| ZA (1) | ZA200210304B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60020366T2 (en) | 1999-06-14 | 2006-02-02 | Genentech Inc., San Francisco | STRUCTURED PEPTIDE EQUIPMENT FOR EXHIBITING ROTATION LIBRARIES TO PHAGE |
| US20030166003A1 (en)* | 1999-06-14 | 2003-09-04 | Cochran Andrea G. | Structured peptide scaffold for displaying turn libraries on phage |
| US7078376B1 (en) | 2000-08-11 | 2006-07-18 | Baxter Healthcare S.A. | Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
| US6914123B2 (en) | 2001-04-17 | 2005-07-05 | Genentech, Inc. | Hairpin peptides with a novel structural motif and methods relating thereto |
| US7348004B2 (en)* | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| EP3552627A1 (en) | 2003-05-06 | 2019-10-16 | Bioverativ Therapeutics Inc. | Clotting factor-fc chimeric proteins to treat hemophilia |
| HRP20120989T1 (en)* | 2003-05-12 | 2013-01-31 | Affymax, Inc. | Peptides that bind to the erythropoietin receptor |
| MXPA05012314A (en)* | 2003-05-12 | 2006-04-18 | Affymax Inc | Spacer moiety for poly(ethylene glycol) -modified peptides. |
| EP2336162A1 (en)* | 2003-05-12 | 2011-06-22 | Affymax, Inc. | Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| JP4266028B2 (en)* | 2003-05-12 | 2009-05-20 | アフィーマックス・インコーポレイテッド | A novel peptide that binds to the erythropoietin receptor |
| US7589063B2 (en) | 2004-12-14 | 2009-09-15 | Aplagen Gmbh | Molecules which promote hematopoiesis |
| WO2006089228A2 (en) | 2005-02-16 | 2006-08-24 | Nektar Therapeutics Al, Corporation | Conjugates of an epo moiety and a polymer |
| US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
| EP1857463A1 (en)* | 2006-05-03 | 2007-11-21 | Ebewe Pharma Ges.m.b.H. Nfg. KG | Peptide having neuroprotective effects |
| EP2035041B1 (en) | 2006-06-30 | 2020-01-08 | Syntab Therapeutics GmbH | Conjugates for innate immunotherapy of cancer |
| CA2676820A1 (en) | 2007-01-31 | 2008-08-07 | Affymax, Inc. | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
| EP2018835B1 (en) | 2007-07-09 | 2014-03-05 | Augustinus Bader | Agent-eluting plaster |
| CN104689298A (en)* | 2008-01-22 | 2015-06-10 | 阿拉伊姆药品公司 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| ES2604668T3 (en) | 2009-02-05 | 2017-03-08 | Immunogen, Inc. | New benzodiazepine derivatives |
| RU2410392C2 (en) | 2009-02-16 | 2011-01-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН | Dipeptide mimetics of ngf and bdnf neurotrophins |
| WO2012003960A1 (en) | 2010-07-06 | 2012-01-12 | Augustinus Bader | Topical application of erythropoietin for the treatment of eye disorders and injuries |
| CN113896731A (en)* | 2011-02-15 | 2022-01-07 | 伊缪诺金公司 | Cytotoxic benzodiazepine derivatives |
| CN105517561A (en)* | 2013-07-17 | 2016-04-20 | 阿拉伊姆药品公司 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| CN105017406B (en)* | 2014-04-21 | 2020-10-09 | 上海市第一人民医院 | A new class of peptides with neuroprotective function |
| CN105233256A (en)* | 2015-10-28 | 2016-01-13 | 中国人民解放军第三军医大学 | Application of erythropoietin and erythropoietin derivatives to preparation of medicine for promoting apoptotic cell clearance during disease treatment |
| GB201609083D0 (en) | 2016-05-24 | 2016-07-06 | Syntab Therapeutics Gmbh | Synthetic compound |
| WO2020054813A1 (en)* | 2018-09-14 | 2020-03-19 | エポメッド株式会社 | Anti-erythropoietin receptor peptide |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5767078A (en)* | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
| WO2000024782A2 (en)* | 1998-10-23 | 2000-05-04 | Amgen Inc. | Modified peptides, comprising an fc domain, as therapeutic agents |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6165783A (en)* | 1997-10-24 | 2000-12-26 | Neuro Spheres Holdings Ltd. | Erythropoietin-mediated neurogenesis |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5767078A (en)* | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
| WO2000024782A2 (en)* | 1998-10-23 | 2000-05-04 | Amgen Inc. | Modified peptides, comprising an fc domain, as therapeutic agents |
| Title |
|---|
| See also references ofWO0191780A1* |
| Publication number | Publication date |
|---|---|
| CN1452492A (en) | 2003-10-29 |
| AU7490401A (en) | 2001-12-11 |
| CA2410453A1 (en) | 2001-12-06 |
| EP1296702A1 (en) | 2003-04-02 |
| MXPA02011727A (en) | 2003-10-24 |
| AU2001274904B2 (en) | 2006-08-31 |
| IL153079A0 (en) | 2003-06-24 |
| WO2001091780A1 (en) | 2001-12-06 |
| HK1058484A1 (en) | 2004-05-21 |
| ZA200210304B (en) | 2004-03-19 |
| JP2003534384A (en) | 2003-11-18 |
| BR0111182A (en) | 2004-02-25 |
| CN1318084C (en) | 2007-05-30 |
| NZ522924A (en) | 2004-12-24 |
| Publication | Publication Date | Title |
|---|---|---|
| AU7490401A (en) | Neuroprotective peptides | |
| GB0014870D0 (en) | Peptides | |
| GB0128994D0 (en) | Peptides | |
| SI1294381T1 (en) | Neuroprotective 7-beta-hydroxysteroids | |
| GB0029777D0 (en) | Peptides | |
| AU6268901A (en) | Oligopeptides | |
| EP1147130A4 (en) | Alpha-conotoxin peptides | |
| GB0001825D0 (en) | Peptides | |
| GB0120713D0 (en) | Peptides | |
| GB0007263D0 (en) | Peptides | |
| EP1323731A4 (en) | Novel peptides | |
| GB0018307D0 (en) | Polypeptides | |
| GB0021475D0 (en) | Anti-aniogenic peptides | |
| GB0010327D0 (en) | Peptides | |
| GB0007264D0 (en) | Peptides | |
| GB0001826D0 (en) | Peptides | |
| GB0113257D0 (en) | Polypeptides | |
| GB9907911D0 (en) | Peptides | |
| GB9928325D0 (en) | Peptides | |
| TJ20000630A (en) | Photosensetive material | |
| GB0029850D0 (en) | Modifying material | |
| GB0021877D0 (en) | Novel peptide sequence | |
| GB0017431D0 (en) | Novel peptide sequence | |
| GB0117737D0 (en) | Modified peptides | |
| GB0125372D0 (en) | Modified peptides |
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| 17P | Request for examination filed | Effective date:20021213 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated state(s):AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR | |
| AX | Request for extension of the european patent | Extension state:AL LT LV MK RO SI | |
| A4 | Supplementary search report drawn up and despatched | Effective date:20050322 | |
| 17Q | First examination report despatched | Effective date:20070330 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN | |
| 18D | Application deemed to be withdrawn | Effective date:20110615 |